Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Withdrawn × NET × Clear all

Phase

Phase 2 6 Phase 1/2 2 Phase 1 2 Phase NA 1 Phase EARLY_PHASE1 1 Phase 4 1 Phase 3 1

Status

Completed 7 Recruiting 4 Withdrawn 1 Unknown 1 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 12 Breast 11 Lymphoid 5 Tumor-Agnostic 4 Other hematologic neoplasm 3 Genitourinary 3 Classical hematology 3 CNS 3 Thoracic 2 Plasma cell 2 Head & Neck 2 Other 1 NET 1 Myeloid 1 Gynecologic 1 Endocrine 1 Dermatologic 1

Conditions

Hypoglycemia 1 Gastro-enteropancreatic neuroendocrine tumor 1

Interventions

pasireotide 1 Diazoxide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02779257 2022-03-04

Pasireotide Treatment for Neuroendocrine Tumor

University of Maryland, Baltimore

Phase 4 Withdrawn

EndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor, Hypoglycemia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡